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Abstract
Background: tmRNA acts first as a tRNA and then as an mRNA to rescue stalled ribosomes in
eubacteria. Two unanswered questions about tmRNA function remain: how does tmRNA, lacking
an anticodon, bypass the decoding machinery and enter the ribosome? Secondly, how does the
ribosome choose the proper codon to resume translation on tmRNA? According to the -1 triplet
hypothesis, the answer to both questions lies in the unique properties of the three nucleotides
upstream of the first tmRNA codon. These nucleotides assume an A-form conformation that
mimics the codon-anticodon interaction, leading to recognition by the decoding center and choice
of the reading frame. The -1 triplet hypothesis is important because it is the most credible model
in which direct binding and recognition by the ribosome sets the reading frame on tmRNA.
Results: Conformational analysis predicts that 18 triplets cannot form the correct structure to
function as the -1 triplet of tmRNA. We tested the tmRNA activity of all possible -1 triplet mutants
using a genetic assay in Escherichia coli. While many mutants displayed reduced activity, our findings
do not match the predictions of this model. Additional mutagenesis identified sequences further
upstream that are required for tmRNA function. An immunoblot assay for translation of the
tmRNA tag revealed that certain mutations in U85, A86, and the -1 triplet sequence result in
improper selection of the first codon and translation in the wrong frame (-1 or +1) in vivo.
Conclusion: Our findings disprove the -1 triplet hypothesis. The -1 triplet is not required for
accommodation of tmRNA into the ribosome, although it plays a minor role in frame selection.
Our results strongly disfavor direct ribosomal recognition of the upstream sequence, instead
supporting a model in which the binding of a separate ligand to A86 is primarily responsible for
frame selection.
Background
Eubacteria possess a quality control system that rescues
ribosomes stalled on defective mRNA templates. The key
player in this system is transfer-messenger RNA (tmRNA),
so called because it functions both as tRNA and mRNA.
Aminoacylated tmRNA enters the empty A-site of stalled
ribosomes and transfers alanine to the nascent polypep-
tide as would a normal tRNA. The ribosome then resumes
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addition of another 10 amino acids to the nascent
polypeptide [1]. As a result of tmRNA action, stalled ribos-
omes are released and recycled and the aborted protein
product is tagged for destruction by proteases (for reviews,
see [2-5]).
In the trans-translation model of tmRNA function
described above, two steps occur that are difficult to rec-
oncile with our current understanding of the mechanism
of translation. The first is tmRNA entry into stalled ribos-
omes and its accommodation in the A-site despite the
absence of a codon-anticodon interaction. In normal
decoding, the ribosome monitors the geometry of the
double helix formed by the codon and anticodon pair.
Adenosines at positions 1492 and 1493 in the 16S ribos-
omal RNA form A-minor motif interactions with the A-
form helix [6,7]. When the pairing is recognized as correct,
elongation factor Tu hydrolyzes GTP, allowing the tRNA
to be accommodated into the A-site and the chemistry of
peptidyl transfer to proceed. tmRNA cannot participate in
a codon-anticodon interaction; although it has a tRNA-
like domain (TLD), it lacks an anticodon loop [8,9]. Fur-
thermore, tmRNA can only enter ribosomal A-sites devoid
of mRNA [10].
The second puzzling step in trans-translation is that the
ribosome switches templates in the course of synthesizing
a single polypeptide. How does the ribosome leave the
stalled mRNA and resume elongation on tmRNA in the
correct frame? Nearby structural elements contribute sur-
prisingly little to positioning the first tmRNA codon in the
decoding center. This 'resume' codon lies 12 nucleotides
downstream from pseudoknot 1 (Figure 1A), which like
the other three pseudoknots can be replaced by unrelated
sequences without loss of activity [11]. Likewise, the tag
template after the resume codon can be altered with little
or no effect [12]. It appears that the crucial sequence acts
Secondary structure of tmRNA and detail of the sequence upstream of the first codon of the tmRNA templateFigure 1
Secondary structure of tmRNA and detail of the sequence upstream of the first codon of the tmRNA tem-
plate. (A) Secondary structure of Escherichia coli tmRNA, including the tRNA-like domain (TLD), four pseudoknots (PK1–4), 
with boxes surrounding the resume and stop codons at either end of the tag template [40]. (B) Fragment of a tmRNA 
sequence containing the -1 triplet (GUC) and resume codon (gca). (C) Results of the KanR assay [11] for independent mutants 
in the sequence upstream of the resume codon (see the text). ++ denotes survival at high stringency (30 μg/ml kanamycin at 
37°C); +/- denotes survival at low stringency only (15 μg/ml kanamycin at 25°C); - denotes no survival at either stringency. (D) 
Sequence logo displaying the consensus of all 555 natural tmRNA sequences [21,41]. Created by Weblogo [42].Page 2 of 10
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of the resume codon sets the precise frame [13-15]. Muta-
tion of this upstream sequence (UAGUC) leads to shifting
of the frame of the tag sequence in vitro [13]. How the
upstream sequence sets the frame on tmRNA is unknown.
It may involve direct binding to the ribosomal decoding
center or an interaction through another ligand.
A recent hypothesis put forward by Lim and Garber
addresses both of these questions by proposing a function
for the three nucleotides immediately preceding the
resume codon [16]. They propose that this '-1 triplet'
forms an A-form structure even in its unpaired state; this
structure mimics the codon-anticodon interaction and
binds directly to the ribosomal decoding center. In addi-
tion to allowing ribosomal entry and accommodation,
this recognition event also establishes the reading frame
on tmRNA. Following peptidyl transfer and translocation
by one codon, the resume codon is moved into the A-site
to act as a template for the continuation of translation.
Lim and Garber predict that not all 64 nucleotide triplets
can assume an A-form conformation when single-
stranded [16]. For 'forbidden' triplet sequences, the A-
form conformation is dramatically destabilized because
potential hydrogen bonds are not made. In earlier work,
Lim and Curran showed that in the natural decoding proc-
ess, mismatched codon-anticodon pairing leaves poten-
tial hydrogen bonding sites unsatisfied, preventing the
formation of A-form helices [17]. In the case of the
unpaired -1 triplet of tmRNA, conformational analysis
predicts that large size differences (or steps) between adja-
cent bases prevent solvent molecules from satisfying all
potential hydrogen bonds. Large steps are formed by
sequences in which purines follow pyrimidines (for exam-
ple, UG or CA). If A rotates to the syn-conformation, the
size of the step is reduced: UA and CA are allowed unless
followed by G (ruling out the triplet UAG).
According to these rules, the 18 forbidden triplets under-
lined in Table 1 cannot function as the -1 triplet in tmRNA
[16]. Lim and Garber note that all natural tmRNA -1 tri-
plet sequences are allowed by their rules. They also cite an
earlier study in which 10 mutant -1 triplets were assayed
in vitro, demonstrating that only the single forbidden tri-
plet resumed some of the time in the wrong frame [13].
Although these facts fit their model, their hypothesis still
lacks direct experimental support.
The -1 triplet hypothesis is important because it is the
most credible model for reading-frame selection that pos-
tulates direct binding of the ribosome to the tmRNA
upstream sequence. Here we report a direct test of its pre-
dictions: we assayed all 64 possible sequences for tmRNA
function. We show that the rules formulated by Lim and
Garber do not accurately predict which -1 triplet mutants
are functional in Escherichia coli cells. All of the mutants
display measurable levels of tmRNA function in vivo,
albeit at various levels. We conclude that the upstream
sequence is not involved in the accommodation process,
although the -1 triplet does play a minor role in setting the
frame. These findings provide a counterargument to direct
recognition of the upstream sequence by the ribosomal
decoding center. Analysis of mistaken frame selection in
several tmRNA mutants supports a model in which A86 is
recognized by a ligand, placing the resume codon appro-
priately into the ribosomal A-site.
Methods
Plasmid construction
The ssrA gene in the plasmid p16Dum-Cat [11] was
altered to express tmRNA mutants with every possible -1
triplet. The ssrA tag template sequence encodes the last 14
amino acids of the kanamycin resistance protein (KanR),
ANKLQFHLMLDEFF, instead of the normal degradation
tag, ANDENYALAA. p16Dum-Cat also expresses a trun-
cated KanR protein lacking the C-terminal 15 amino
acids, with the sequence Glu-Pro-Opal added to the C-ter-
minus to induce ribosome stalling. Expression of this pro-
tein construct is driven from an arabinose-inducible
promoter.
The 64 possible -1 triplet mutations were generated as a
random library in the p16Dum-Cat vector. The oligonu-
Table 1: Activity of tmRNA -1 triplet mutants in the KanR assay
UUU X UCU X UAU X UGU X
UUC 10 UCC 100 UAC 25 UGC 100
UUA X UCA 35 UAA X UGA X
UUG X UCG 100 UAG 100 UGG 50
CUU X CCU X CAU 40 CGU X
CUC 50 CCC 50 CAC 100 CGC 60
CUA X CCA 100 CAA X CGA X
CUG 100 CCG 100 CAG 90 CGG 20
AUU 90 ACU X AAU 90 AGU 100
AUC 100 ACC 100 AAC 80 AGC 100
AUA 60 ACA 100 AAA 100 AGA 100
AUG 100 ACG 100 AAG 100 AGG 100
GUU 90 GCU X GAU 100 GGU 100
GUC 100 GCC 100 GAC 100 GGC 100
GUA X GCA X GAA 95 GGA 100
GUG 100 GCG 25 GAG 100 GGG 100
tmRNA directs the addition of the last 15 amino acids of KanR onto 
ribosomes stalled on a kanR template in Escherichia coli. Only cells 
with functional tmRNA survive on 30 μg/ml kanamycin [11]. Each -1 
triplet mutant was tested individually and the data reported as 
percentage survival on selective (kanamycin) media. Triplets listed as 
X showed no survival. Triplets forbidden by the rules developed by 
Lim and Garber [16] are underlined and in bold type.Page 3 of 10
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AAAAAGCCGCAAAAAATANNNGCAAATAAACTGCAGTT
TCAT was synthesized with a random mixture of all four
nucleotides at positions 87–89 of tmRNA (underlined). A
short primer that anneals to the constant 3' region of this
oligonucleotide was extended by the Klenow fragment of
DNA polymerase I to generate double-stranded DNA. The
resulting insert was digested with SphI and PstI, ligated
into the p16Dum-Cat vector, and introduced into electro-
competent X90 ssrA::cat cells [1]. Clones from the result-
ing library were sequenced to identify plasmids expressing
the 64 different -1 triplet mutant tmRNAs.
tmRNA expression vectors for the bacteriophage assays are
derivatives of pKW11 [12]. Only the nucleotides listed are
mutated in the tmRNA expressed from these plasmids; the
rest of the sequence, including the tag template, is the
same as wild-type E. coli tmRNA. The following mutations
were incorporated separately into pKW11: UUG, UCG,
UAG, UGG, or UGU as the -1 triplet, and the additional
mutants U85A, and A86C. For example, in making the
UUG mutant, primers 5pktrip: GCAAACGACGAAAAC-
TACGCTTTAG and 3uug: CAATATTTTTTGCGGCTTTT-
TACGAGGCC were used to amplify the entire pKW11
plasmid in an inverse polymerase chain reaction (PCR).
The blunt ends were phosphorylated with polynucleotide
kinase and ligated together.
The plasmids that express tmRNA mutants for the frame
misreading assays are based on pCH201, a derivative of
pKW11 with a tmRNA tag template encoding ANDH6D
[18]. The upstream sequence of pCH201 was altered to
separately incorporate the following mutations: UGU or
UUG as the -1 triplet, U85A, and A86C. Addition of the
nucleotides GC before the tag sequence (G90) ensures
that the His6 tag is added only if tmRNA is read by the
ribosome in the -1 frame. For example, the oligonucle-
otides 5'his6: GCAAACGACCATCACCACCATCATCAC-
GATTAATAAC and 3'gtc: GCGACTATTTTTTGCGGCTTTT
TACGAGGCCAACC were used to amplify pCH201 in an
inverse PCR, as above, to create the wild-type upstream
sequence in the -1 frame plasmid. For the +1 frame plas-
mids, one extra nucleotide (G) was added before the
resume codon such that the His6 tag is added only if
tmRNA is read in the +1 frame.
KanR assay for tmRNA activity
In the KanR assay, functional tmRNA molecules rescue
ribosomes stalled on a truncated KanR protein and syn-
thesize full-length KanR, rendering the cells resistant to
kanamycin [11]. Bacteria containing each tmRNA mutant
were grown overnight from a single colony in 2xYT with
ampicillin. Cultures were diluted 10-fold into fresh media
containing 2% arabinose and grown for 2 hours at 37°C
to induce expression of the KanR protein. The cells were
plated onto selective media: 2xYT, ampicillin, 2% arab-
inose, and 30 μg/ml kanamycin. Growth comparisons
(selective versus non-selective plates) were made after
incubation for 24 hours at 37°C. Select mutants were
assayed again at lower stringency: 15 μg/ml kanamycin,
25°C and scored after 48 hours.
Phage efficiency of plating assays
X90 ssrA::cat cells carrying -1 triplet mutants of tmRNA
expressed from pKW11 were assayed for plaque formation
using the phage λimmP22 c2-dis as described [11]. The
number of plaques were counted for three different trials
as reported in Figure 2.
Western blot analysis of misreading
The -1 or +1 misreading vectors express tmRNA with
frameshifted tags such that the ANDH6D tag is only added
to stalled nascent peptides if the ribosome reads tmRNA
in the correct frame. The plasmid pFLAG-MBP-SEP*
expresses the complete maltose binding protein (MBP)
containing an N-terminal FLAG tag and the amino acid
sequence Glu-Pro-Opal added to the C-terminus, causing
stalling during translational termination. X90 ssrA::cat
cells containing one tmRNA plasmid and pFLAG-MBP-
SEP* were grown in tetracycline and ampicillin to an
OD600 of 0.5 and the expression of MBP induced with 1
mM IPTG. After 2.5 hours, the cells were pelleted and
lysed with sodium dodecyl sulfate (SDS). Protein in the
crude lysate was quantified via a Lowry assay and 12 μg of
protein for each sample was resolved by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). The protein was transferred to polyvinylideneflu-
oride (PVDF) membrane and His6-tagged MBP was
bound by a mouse anti-His6 antibody (Cell Signaling
Analysis of -1 triplet mutant activityFigure 2
Analysis of -1 triplet mutant activity. The hybrid bacte-
riophage λimmP22 c2-dis only forms plaques on cells express-
ing active tmRNA [3,19]. Data are expressed as efficiency of 
plating (EOP) with wild-type tmRNA taken as EOP = 1. The 
del-ssrA mutant lacks tmRNA. Error bars represent the 
standard deviation of three independent experiments.Page 4 of 10
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(Sigma) to MBP was used to control for protein expression
and loading (not shown). Fluorescent secondary antibod-
ies (anti-mouse IRDye 800 and anti-rabbit IRDye 680, LI-
COR Biosciences) were added and the blot was visualized
with the Odyssey Infrared Imaging System (LI-COR Bio-
sciences).
Results
In vivo KanR assay of all possible -1 triplet mutations in 
tmRNA
We examined the hypothesis that the tmRNA -1 triplet
mimics a codon-anticodon helix and is recognized by the
ribosome decoding center. According to the rules derived
by Lim and Garber, 18 forbidden codons cannot assume
the correct A-form structure as unpaired RNA (underlined
in Table 1) [16]. We tested the function of tmRNA
mutants corresponding to all possible -1 triplets. Our
assay links tmRNA activity to the survival of E. coli cells by
requiring trans-translation to complete the synthesis of a
necessary protein. The tmRNA template sequence was
altered to encode the last 14 amino acids of the kanamy-
cin resistance protein (KanR). Ribosome stalling at the
end of a truncated KanR protein leaves the cells sensitive
to kanamycin unless tmRNA rescues the ribosome and
directs the synthesis of full-length, active KanR protein.
This assay was used previously to characterize mutants of
tmRNA pseudoknot 1 and is a sensitive measure of in vivo
tmRNA function [11].
E. coli cells containing a single -1 triplet mutant were
plated onto selective media containing 30 μg/ml kanamy-
cin at 37°C. Under these conditions, colonies with the
wild-type E. coli -1 triplet sequence, GUC, survive equally
well on selective versus non-selective plates (100%).
Eighteen of the 64 mutant triplets showed no growth on
selective plates, indicating decreased tmRNA activity
(Table 1). Of these 18 dead mutants, only five had -1 tri-
plet sequences that were forbidden by the rules described
above. Nine other mutants showed weakened activity,
from 10% to 50% survival. Of these nine, only three were
forbidden. Conversely, eight of the triplets predicted to be
forbidden displayed full activity (100%). We conclude
from these data that the -1 triplet sequence does play a
role in tmRNA activity, but that the rules derived by Lim
and Garber do not accurately predict which sequences
support tmRNA activity in vivo.
Several patterns in our data reveal the sequence determi-
nants for -1 triplet function in tmRNA. The dominant pat-
tern is that pyrimidines U and C are disfavored at
nucleotide 87, the first of the -1 triplet. Of the 27 dead or
weak mutants, 12 begin with U and 10 with C, but only 5
begin with a purine (A or G). At position 88 there seems
to be little nucleotide bias in our data. At position 89, the
last of the -1 triplet, U and A are disfavored (10 and 9
impaired mutants, respectively) compared with 4 each for
C and G. The C89U mutation is particularly inactive when
combined with U or C at position 87: of the eight YNU
sequences, seven are dead and the other is weak. These
two rules, the avoidance of pyrimidines at position 87 and
U or A at position 89, explain the majority of the -1 triplet
mutagenesis results.
In order to further characterize the activity of the 18 dead
mutants, we repeated the assays at lower stringency: 15
μg/ml kanamycin at 25°C. Under these conditions, 15 of
these 18 mutants showed 100% survival. CGA showed
modest activity, but UGU and CGU remained completely
inactive, with no colonies forming on the selective plates.
These two mutants combine the ill effects of defying both
patterns seen above, as they have a pyrimidine at position
87 and U at position 89. The fact that two -1 triplet
mutants have no measurable activity in the KanR assay
highlights the importance of these three nucleotides for
tmRNA function. On the other hand, the fact that 61 of
the 64 mutants show substantial tmRNA activity (at vari-
ous levels) demonstrates that the role of this sequence is
subtle, more likely fine-tuning function rather than the
critical step of licensing tmRNA entry and accommoda-
tion.
In vivo KanR assay of additional mutants in the upstream 
sequence
To identify other nucleotides that may play a role in
accommodation or frame selection, we used the KanR
assay to systematically test the role of the remaining
nucleotides upstream of the resume codon. Between pseu-
doknot 1 and the coding sequence lies the 11 nucleotide
sequence AAAAAAUAGUC, of which the final GUC
sequence is the -1 triplet (Figure 1A and 1B). The sur-
rounding pk1 structure [11] and coding sequence [12,13]
can be altered without affecting the ability of tmRNA to
rescue stalled ribosomes, suggesting that these 11 nucle-
otides contain the determinants for identifying the
resume codon.
In accordance with their low conservation, the six adenos-
ines at the 5'-end of this sequence tolerate alterations. To
test the importance of distance constraints, we shortened
(A84del) and lengthened (A84ins) the run of six A's by
one nucleotide. Analysis in the KanR assay revealed that
one extra A had no effect in the A84ins mutant. Deletion
of one A resulted in weaker activity, with growth only at
low stringency. (Hereafter mutants will be scored on their
survival at low and high stringency; for example, +,- for
the A84del mutant.) To examine sequence dependence,
we mutated the A's in this sequence to C two nucleotides
at a time. These mutants displayed modest (AA79CC +,-)
or high activity (AA81CC and AA83CC both +,+); see Fig-Page 5 of 10
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the run of six A's is not critical and that changes in length
are tolerated.
We mutated the highly conserved U85 and A86 to each of
the three alternative nucleotides (Figure 1C). Mutation of
U85 to C or G had no adverse affect (+,+) while the U85A
mutation supported survival only on the low-stringency
KanR assay (+,-). In contrast to the tolerance for changes
at position 85, all mutations of A86 dramatically reduced
activity. The A86G mutation survived only modestly
(~50%) at low stringency (+,-). Mutation of A86 to pyri-
midines C and U yielded no measurable activity in the
KanR assay (-,-). Unlike single nucleotide mutations in
the -1 triplet region, which had little or no effect, muta-
tion of A86 alone destroys tmRNA activity. These results
show that A86 plays a major role in tmRNA function, an
observation consistent with the nearly complete conserva-
tion of A86 in tmRNA sequences (Figure 1D).
Analysis of upstream mutants by bacteriophage plaque 
formation
To test the function of these tmRNA mutants in a second
in vivo assay, we introduced mutations into otherwise
wild-type tmRNA (encoding the natural tag ANDENYA-
LAA) and assayed their ability to support phage plaque
formation. The hybrid bacteriophage λimmP22 c2-dis only
forms plaques on bacteria with intact trans-translation sys-
tems. Cells expressing wild-type tmRNA support the
growth of around 105 more plaques than cells expressing
no tmRNA [3,19]. In order to support phage growth,
tmRNA mutants must be able to enter the ribosome,
resume translation on the tmRNA template, and bring
about termination at a stop codon [20]. The phage assay
requires only release of the ribosomes, not proper frame
choice or destruction of the aborted polypeptide [19].
Several -1 triplets that are forbidden by the rules of Lim
and Garber were assayed for activity in the phage assay.
The four UNG triplets were chosen because they exhibited
varied levels of activity in the high-stringency KanR assay:
UCG and UAG show 100% survival, while UGG was
weaker at 50% and UUG showed no survival. All four of
these mutant -1 triplets supported phage plaque forma-
tion as well as the wild-type control (Figure 2). We tested
our most deleterious mutant, UGU, which did not survive
in the KanR assay even under low-stringency conditions,
and found that it too supported plaque formation as well
as wild-type tmRNA. The wild-type level activity of these
five forbidden triplets adds further evidence that the rules
of Lim and Garber do not predict tmRNA activity in vivo.
We conclude that the -1 triplet sequence is not required
for any essential function of tmRNA in the phage assay,
including tmRNA entry into the ribosome and accommo-
dation into the A-site.
It appears that the phage assay is less sensitive than the
KanR assay, in which subtle changes in levels of tmRNA
activity were distinguished. This may be because tmRNA
activity is close to the threshold required for survival in
the KanR assay. In addition, small changes in tmRNA
function caused by mutations are further amplified by the
KanR enzymatic activity. In contrast, the threshold
tmRNA function required for plaque formation in the
phage assay is fairly low [20]. Another difference is that
since the function of the tag peptide is not critical, proper
frame selection is not required for phage propagation as,
unlike in the KanR assay where it is required.
Mutations upstream of the resume codon alter frame 
recognition on the tmRNA template
In vitro experiments show that mutations in the UAGUC
sequence immediately upstream of the resume codon
affect frame recognition. The U85A mutation, for exam-
ple, causes the tag sequence to be read in the -1 frame 45%
of the time in vitro [13]. To characterize frame misrecogni-
tion in living E. coli cells, we altered the tmRNA template
sequence to encode ANDH6D, allowing tagging to be
detected by an anti-His6 antibody. Two constructs were
created: the first has two nucleotides inserted between the
UAGUC sequence and the resume codon (GCA), such
that the His6-containing peptide tag is only synthesized
when tmRNA is read in the -1 frame. A second construct
with a one-nucleotide insertion creates a template that
produces the ANDH6D tag when read in the +1 frame.
These tmRNA constructs allow visualization of tagging in
the -1 or +1 frame for any given tmRNA mutant.
Three -1 triplet mutants of varying activity were analyzed:
GUC (wild-type and +,+), UUG (+,-), and UGU (-,-), as
well as the U85A (+,-) and A86C (-,-) mutations. The com-
plete MBP with a stall-inducing sequence (Glu-Pro-Opal)
at the C-terminus served as a substrate for tagging. The
addition of the ANDH6D tag was monitored by immuno-
blot with anti-His6 antibodies. Analysis of tagging in the -
1 frame vectors reveals one reason behind the low activi-
ties of the U85A and UGU mutants. As seen in previous in
vitro studies, U85A exhibited increased translation in the -
1 frame. Our results show both the U85A and UGU muta-
tions lead to tag translation in the -1 frame at a 2.5-fold
higher level than wild-type (Figure 3B). Comparison with
a standard amount of tagged protein allows us to estimate
that these mutants tag in the -1 frame at roughly 20% of
wild-type tagging levels (Figure 3A).
Analysis of tagging in the +1 frame vectors shows no mis-
reading, with one exception. The A86C mutant resumes
translation in the +1 frame at a very high level, compara-
ble to the G87 deletion mutant used as a positive control.
Deletion of G87 restores the template sequence to the
proper frame, negating the extra nucleotide added beforePage 6 of 10
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with a known amount of tagged protein suggests that
these mutants yield +1 tagged proteins about 50% as effi-
ciently as wild-type tmRNA reading in the 0 frame (Figure
3A). This is a much stronger signal than seen for the -1
frame misreading above. This result is surprising because
it was reported that the A86C mutant shows no activity
whatsoever in vitro [13] and the A86C mutant showed no
activity in the phage assay (Figure 2) as reported [15]. We
speculate that these differences result from the different
tag template sequences used for the various assays (dis-
cussed in the following).
Discussion
The entry of tmRNA into stalled ribosomes to serve first as
a tRNA and then as an mRNA template poses two prob-
lems for our current understanding of translation. First,
how does tmRNA get past the decoding center when it
lacks an anticodon and enters an A-site devoid of mRNA?
Secondly, how does the ribosome resume translation on
tmRNA at the proper site and in the proper frame? The -1
triplet hypothesis of Lim and Garber [16] suggests that
three nucleotides immediately upstream of the resume
codon mimic an codon-anticodon pair and bind directly
to the ribosomal decoding center. Lim and Garber derived
rules based on conformational analysis that predict which
triplets can assume an A-form conformation as single-
stranded RNA [16].
Using the KanR assay, which ties the life of E. coli cells to
the function of tmRNA [11], we directly assayed each -1
triplet mutant for tmRNA activity. We found that eight of
the 18 forbidden mutants showed activity indistinguisha-
ble from wild-type. Conversely, of the 18 mutants that
were completely inactive, only five were predicted to be
forbidden. Our data support the idea that the -1 triplet
sequence is important to tmRNA function, but they do
not fit the rules developed by Lim and Garber (Table 1).
Instead, our data show that purines are highly favored at
position 87 (the first of the -1 triplet) and that U and A are
somewhat disfavored at position 89.
These characterizations broadly fit the natural distribu-
tion of -1 triplet sequences (Figure 1D). The preference for
purines at position 87 matches the consensus obtained
from all of the known natural tmRNA sequences [21], in
which A and G occur roughly equally with only a negligi-
ble number of pyrimidines. There seems to be no nucle-
otide preference at the middle position in either our data
or the consensus sequence. At position 89, C and U are
equally represented in natural tmRNA sequences and
strongly preferred to A or G. In our data, U is underrepre-
sented at position 89 in active sequences. Perhaps this is
because seven of the nine inactive sequences containing
U89 have a pyrimidine at position 87. For example, the
UGU and CGU mutants display no detectable activity
even in the low-stringency KanR assay. Going against both
of these trends appears to be particularly deleterious. As
natural -1 triplets nearly always begin with purines, U89
may be more acceptable in the natural pool of sequences.
We performed a second assay based on the efficiency of
plaque formation by the hybrid phage λimmP22 c2-dis.
This phage can only form plaques on cells with active
trans-translation systems [3,19]. We assayed five -1 triplet
mutants ranging in the KanR assay from fully active to
completely inactive under our lowest stringency condi-
tions (UGU). We found that all five of these mutants had
activities that were indistinguishable from wild-type
tmRNA in the phage assay (Figure 2). All five of these -1
triplet sequences were forbidden by Lim and Garber's
rules. The results of these two assays suggest that the -1 tri-
Assay for misreading of the resume codon by tmRNA triplet mutantsFigure 3
Assay for misreading of the resume codon by 
tmRNA triplet mutants. (A) tmRNA mutants were 
altered to encode the ANDH6D peptide tag provided that 
the ribosome resumes translation in the -1 (top) or +1 (bot-
tom) frames. The maltose-binding protein with a stalling sig-
nal at the C-terminus served as a substrate for tagging, which 
was detected by anti-His6 antibodies. Addition of a known 
standard (tmRNA tagging in the 0 frame) at a 1:5 dilution 
allows comparison with the natural, 0 frame tagging process. 
(B) Quantification of tagging in the -1 frame relative to GUC 
(wild-type). Error bars represent the standard deviation of 
three independent experiments. (C) Proposed helical struc-
ture surrounding the resume codon (boxed) in the A86C 
mutant.Page 7 of 10
(page number not for citation purposes)
BMC Biology 2008, 6:29 http://www.biomedcentral.com/1741-7007/6/29plet sequence does not serve as a codon-anticodon mimic
nor interact directly with the decoding center in a manner
essential to tmRNA accommodation in the A-site.
A recent study by Shimizu and Ueda provides further evi-
dence that the tmRNA -1 triplet sequence, and indeed the
whole template sequence, is not required for ribosome
binding, A-site accommodation, or peptidyl transfer [22].
Using a reconstituted translation system in vitro, they
detected polyalanine synthesis with the SmpB protein and
a tmRNA consisting of only the TLD. In this system, the
growing polyalanine chain is passed from one tmRNA
TLD to the next. The ability of tmRNA lacking a template
sequence to bind ribosomes and transfer Ala proves that
only the TLD and SmpB protein are required for the tRNA
activity of tmRNA. In addition, the revised cryo-EM struc-
ture of SmpB and tmRNA bound to the 70S ribosome
shows the SmpB C-terminus binding near the decoding
center in the 16S rRNA [23]. Although the unstructured C-
terminal tail is not visible in this structure, it is the most
likely candidate for sending a signal equivalent to codon-
anticodon pairing.
The -1 triplet is not required for legitimizing tmRNA entry
into the ribosome, but together with U85 and A86, it does
play a role in setting the correct frame for translation to
resume. Analysis of tagging in the -1 frame reveals that
both the deleterious UGU -1 triplet mutation and the
U85A mutation increase translation in the -1 frame by a
factor of 2.5 compared with wild-type (Figure 3B). The
A86C mutation strongly induces +1 misreading. This ten-
dency to select the wrong resume codon is one likely cause
for the inactivity of these sequences in the KanR assay.
Analysis of the A86C mutation by phage assay (Figure 2)
and in vitro tagging assays indicate that this mutation
completely destroys tmRNA activity [13,15]. No ribosome
release or tagging is seen in this mutant. These data con-
tradict our finding that in the misreading assays the A86C
mutant shifts the resume codon strongly to the +1 frame.
The explanation lies in the fact that different tag template
sequences were used in these assays. Chemical probing
experiments show that the upstream region in the A86C
mutant assumes a different structure, presumably a base-
paired structure and therefore impervious to chemical
probes [24]. A possible helical pairing surrounding the
resume codon (between 85–90 and 95–100) would be
further stabilized by the C:G pair created by the A86C
mutation (Figure 3C). This structure could block access to
a ligand that binds the upstream sequence. In our mis-
reading assays, we used an altered tag sequence
(ANDH6D) that cannot form this secondary structure.
Our findings confirm earlier work showing that A86 is the
most important determinant for frame choice on the
tmRNA template [14]. It is the most highly conserved
nucleotide in the upstream sequence. U85 is tolerant to
mutation, except for U85A. We propose that this muta-
tion causes the A86 binding ligand to recognize A85 as
well, shifting the frame back by one nucleotide. This
explains the -1 shift in frame in U85A. The A86G muta-
tion shows very low activity and the C and U mutations
are totally inactive. When the masking effect of an inhibi-
tory structure is removed, A86C causes +1 misreading
because the A86 ligand binds to G87 instead, moving the
resume codon ahead by one nucleotide. A86U has also
been reported to induce +1 misreading in vitro [24]. The
ligand for A86 prefers purines over pyrimidines. The -1 tri-
plet also affects the frame but in a more subtle manner.
The preference for a purine over a pyrimidine at the first
base of this triplet (G87), the strongest trend for these
three nucleotides, likely involves an additional interac-
tion with the A86 ligand.
In contrast with an earlier model that suggested that the
resume codon is positioned inside the ribosome by the
global fold of tmRNA, and the frame fine-tuned by the
upstream sequence [14], we propose that the A86-binding
ligand acts independently to set the frame. The only ribos-
ome binding element on tmRNA that can provide such
positioning is the TLD. The four pseudoknots in tmRNA
can be replaced with unrelated sequences and structures
as can the tag template [11,25]. The distance from pseudo-
knot 1 to U85 is not critical for tagging, but insertions or
deletions between A86 and the resume codon (G90)
cause misreading of the resume codon [13]. It would seem
that the A86-binding ligand is a ruler that establishes the
frame four nucleotides down from A86 by placing the
resume codon in the A-site to act as a template.
The refutation of the -1 triplet hypothesis discredits the
most plausible model for direct binding of the ribosomal
decoding center to the upstream sequence of tmRNA. The
frame misrecognition results are best explained by a sepa-
rate ligand binding to A86 and playing the dominant role
in establishing the frame. What is the A86-binding ligand?
One candidate is ribosomal protein S1, which was shown
to crosslink to U85 in the upstream sequence (as well as
pseudoknots 2 and 3) [26]. Visualization of tmRNA inside
70S ribosomes by cryo-electron microscopy revealed
changes in the structure of the template sequence in ribos-
omes with or without the S1 protein [27,28]. Specifically,
the template sequence is structured and removed from the
decoding center in ribosomes lacking S1. The authors
speculate that free S1 binds tmRNA and stabilizes a func-
tional, open conformation of the template that is then
passed to stalled ribosomes [27]. In support of this model,
one study shows that S1 is dispensable for tmRNA entry
and Ala transfer but required for its mRNA activity in vitro
[29]. On the other hand, the expression of dominant neg-Page 8 of 10
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function although it inhibits normal translation [30].
Bacillus subtilis and other Gram-positive bacteria lack an
S1 protein and yet have tmRNA and functional trans-
translation systems. Two recent in vitro studies using E. coli
or Thermus thermophilus reconstituted translations systems
show that S1 does not affect tmRNA function [31,32]. S1
cannot interact directly with tmRNA on the ribosome, as
S1 binds to the back of the head of the 30S subunit.
A second candidate is SmpB, a protein that enhances ami-
noacylation of tmRNA and is required for entry into the
ribosome (as discussed above). The best characterized
binding site of SmpB is on the TLD of tmRNA, the inter-
action visualized by two co-crystal structures of SmpB and
short fragments of tmRNA [33,34]. Multiple copies of
SmpB can bind tmRNA simultaneously [35,36], however,
even in the context of the 70S ribosome [23]. SmpB bind-
ing also alters the accessibility of the upstream sequence
and pseudoknot 1 to nucleases in probing experiments,
leading to the proposal that it plays a role in frame choice
[36]. This possibility is further strengthened by the recent
finding that SmpB binding protects U85 from chemical
modification and that this protection shifts by one nucle-
otide in tmRNA mutants that induce misreading of the
resume codon [24]. On the other hand, several crosslink-
ing, chemical probing, and hydroxyl-radical cleavage
assays have failed to detect such an interaction [35,37-39].
It is not known which amino acids on SmpB may interact
with the upstream sequence. Through this interaction,
SmpB may orient the template sequence with respect to
the TLD, causing conformational changes in the template,
upstream sequence, and pseudoknot 1, positioning the
resume codon in the A-site. If this model is correct, SmpB
is solely responsible for allowing tmRNA to enter stalled
ribosomes, tricking the decoding center, and it also plays
a crucial role in its interaction with the upstream sequence
on tmRNA to set the frame for translation of the tmRNA
template.
Conclusion
Our findings disprove the -1 triplet hypothesis and
strongly disfavor a model in which ribosome binding
selects the reading frame in tmRNA directly. Binding of a
separate ligand, perhaps S1 or SmpB, to A86 is primarily
responsible for frame choice, although other upstream
sequences including U85 and G87 play a minor role.
Mutations in these nucleotides lead to translation of the
tmRNA in alternate frames in vivo.
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